← Back to Search

Interactive Decision Aid for Menopause

N/A
Waitlist Available
Led By Nananda F Col, MD, MPH, MPP
Research Sponsored by Rhode Island Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Between 45 and 65 years of age
Experience menopausal symptoms or being 6 months or more past last menstrual period
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights

Study Summary

This trial will help create a web-based system to give women personalized feedback on the risks and benefits of different menopause treatments.

Who is the study for?
This trial is for English-speaking women aged 45-65 who are experiencing menopause symptoms or are at least 6 months past their last menstrual period. They must be patients at participating clinics with an upcoming appointment for menopausal counseling or a physical exam.Check my eligibility
What is being tested?
The study is testing a web-based decision aid system designed to help women in menopause understand the risks and benefits of various treatments, providing personalized feedback to assist them in making informed choices.See study design
What are the potential side effects?
Since this trial involves using a web-based informational tool rather than medical treatments, there are no direct side effects associated with traditional medications or interventions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 45 and 65 years old.
Select...
I am experiencing menopause symptoms or it has been 6 months since my last period.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Adherence to medication and lifestyle changes
Anxiety
Decisional conflict
+8 more

Find a Location

Who is running the clinical trial?

Rhode Island HospitalLead Sponsor
260 Previous Clinical Trials
71,438 Total Patients Enrolled
Agency for Healthcare Research and Quality (AHRQ)FED
399 Previous Clinical Trials
6,822,052 Total Patients Enrolled
Nananda F Col, MD, MPH, MPPPrincipal InvestigatorRhode Island Hospital

Media Library

Treatment Clinical Trial Eligibility Overview. Trial Name: NCT00345072 — N/A
Menopause Research Study Groups:
Menopause Clinical Trial 2023: Treatment Highlights & Side Effects. Trial Name: NCT00345072 — N/A
Treatment 2023 Treatment Timeline for Medical Study. Trial Name: NCT00345072 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacancies for participants in this trial?

"As documented on clinicaltrials.gov, the posting of this trial dated back to July 1st 2003 and was last updated in June 2006; currently it is not recruiting participants. However, there are numerous other trials that are actively seeking patients at present."

Answered by AI

What criteria must participants meet to qualify for this trial?

"This trial seeks 296 individuals aged 45-65 who are going through menopause or have experienced it in the past 6 months. Furthermore, participants must be actively seeking counseling for menopausal symptoms or an annual physical exam and enrolled at a participating clinic."

Answered by AI

Does this clinical trial include individuals who have exceeded the age of twenty?

"This trial is only open for members of the population aged 45 to 65. Meanwhile, 4 separate studies are available for minors below 18 and 20 others have been created specifically for individuals above that age range."

Answered by AI
~14 spots leftby Apr 2025